OncLive® and The Ruesch Center for the Cure of Gastrointestinal Cancers Honored the 2018 Honorees of the Second Annual Luminary Awards in GI Cancers

Former U.S. Vice President Joseph R. Biden Jr. was presented with the
2018 Luminary Leadership Award

CRANBURY, N.J.–(BUSINESS WIRE)–OncLive® and The Ruesch Center for the Cure of Gastrointestinal Cancers,
the founding partners of the Luminary Awards in GI Cancers, congratulate
the 2018 honorees recognized at the Second Annual Luminary Awards
ceremony, which was held Thursday, Nov. 29, at the Washington Hilton in
Washington, D.C.


“We are so proud to honor these individuals who have made both a
fundamental and dramatic impact on the lives of so many patients with GI
cancers. While not one of these individuals seeks the spotlight, we feel
it is very important to acknowledge their lifetime contributions and
their dedication to others. This event is by far the Ruesch Center’s
most joyous occasion,” said John L. Marshall, M.D., director of The
Ruesch Center for the Cure of Gastrointestinal Cancers.

“Congratulations to each of our 2018 Luminary Awards in GI Cancers
honorees,” said Michael J. Hennessy Jr., president of MJH Associates
Inc., parent company of OncLive®. “We are so honored that we were able
to celebrate these distinguished leaders who have devoted their time,
talents and resources to improving the lives of patients with
gastrointestinal cancers.”

The 2018 Luminary Awards in GI Cancers honorees are:

  • John S. Macdonald, M.D., FACP; Criterium Inc.
    Macdonald
    is the senior medical advisor for Criterium Inc. He served as the
    medical director and the chief of gastrointestinal oncology at St.
    Vincent’s Comprehensive Cancer Center in New York City, chief of
    medical oncology at St. Vincent’s Hospital and Medical Center and a
    professor of medicine at New York Medical College from 1998 to 2007.
    Macdonald has received numerous awards and distinctions, including
    recognition as one of Good Housekeeping’s Best 300 Doctors in
    America and, over a seven-year period, New York’s Best
    Doctors in New York. He has written more than 400 articles, abstracts
    and book chapters.
  • Michael Sapienza; Colorectal Cancer Alliance
    After losing
    his mother to colon cancer in May 2009, Sapienza turned his grief into
    action, inspiring and challenging the colorectal cancer community and
    his family, friends, and professional associates to follow his lead
    and dedicate themselves to the Colon Cancer Alliance mission. After
    founding the Chris4Life Colon Cancer Foundation and serving as its
    president from 2010 to 2015, he led the effort to merge the alliance
    and the foundation, creating the nation’s largest nonprofit specific
    to colon cancer. Currently, he is the CEO of the Colorectal Cancer
    Alliance and a member of The Ruesch Center for the Cure of
    Gastrointestinal Cancer’s advisory board.
  • Richard L. Schilsky, M.D., FACP, FASCO, FSCT; American
    Society of Clinical Oncology (ASCO)
    A highly respected leader in
    the field of oncology, Schilsky is the senior vice president and the
    chief medical officer of ASCO, as well as a past president.
    Previously, he served as the chief of hematology and oncology in the
    department of medicine and the deputy director of the University of
    Chicago Medicine Comprehensive Cancer Center. He specializes in new
    drug development and treatment of gastrointestinal cancers. His
    impressive experience and proven track record in both clinical
    medicine and clinical research reflect his deep passion for cancer
    medicine. Schilsky has spent most of his career at the University of
    Chicago, where he joined the faculty in 1984, rising to the rank of
    professor of medicine and serving in many roles, including associate
    dean for clinical research in the biological sciences division and
    director of the cancer center. Earlier in his career, he worked in the
    clinical pharmacology branch of the division of cancer treatment at
    the National Cancer Institute and was an assistant professor in the
    department of internal medicine, division of hematology and oncology,
    at the University of Missouri-Columbia School of Medicine. He was also
    the head of the hematology/medical oncology unit at Harry S. Truman
    Veterans’ Hospital in Columbia. Schilsky is also past chair of the
    Cancer and Leukemia Group B and a former member and chair of the Board
    of Scientific Advisors of the National Cancer Institute and of the
    Oncologic Drugs Advisory Committee of the Food and Drug Administration.
  • Paul H. Sugarbaker, M.D., FACS, FRCS; MedStar Washington
    Hospital Center
    Sugarbaker is the chief of the Peritoneal Surface
    Malignancy Program and the director of the Center for Gastrointestinal
    Malignancies at MedStar Washington Hospital Center. In 1989, he became
    the medical director of the Washington Cancer Institute at MedStar
    Washington Hospital Center. Currently, his clinical and investigative
    work is concentrated on the treatment of the peritoneal surface
    dissemination of cancer, known as peritoneal carcinomatosis. He has
    developed, perfected and popularized the combined treatments of cancer
    surgery with warm chemotherapy, infused into the open abdomen toward
    the end of surgical intervention. He has written over 900 articles and
    book chapters, edited seven books, produced 24 videos and received
    four honorary professorships.
  • Daniel D. Von Hoff, M.D., FACP; Translational Genomics
    Research Institute, HonorHealth Clinical Research Institute, US
    Oncology Research, and Mayo Clinic
    Von Hoff is the physician in
    chief and distinguished professor at the Translational Genomics
    Research Institute, chief scientific officer for US Oncology and a
    professor of medicine at the Mayo Clinic. He also holds the Virginia
    Piper Distinguished Chair for Innovative Cancer Research at
    HonorHealth Clinical Research Institute and medical director of
    research at McKesson Specialty Health. Discoveries by Von Hoff and his
    colleagues have led to tremendous improvements in survival for
    patients with pancreatic cancer, and they are currently concentrating
    on the development of molecularly targeted therapies for patients with
    pancreatic and other advanced cancers. Von Hoff has written more than
    675 papers, 140 book chapters and over 1,170 abstracts. He received
    the 2010 David A. Karnofsky Memorial Award from ASCO for his
    outstanding contributions to cancer research that led to significant
    improvement in patient care.

During the awards reception, Joseph R. Biden Jr., former U.S. vice
president and founder of the Biden Cancer Initiative, was also presented
with the 2018 Luminary Leadership Award for his cancer research and
collaboration within the cancer community. Gregory C. Simon, J.D.,
president of the Biden Cancer Initiative, made a special guest
appearance and accepted the Luminary Leadership Award on behalf of Biden
and shared with the audience a special video of the former vice
president accepting the award.

Robert Goldsmith, vice president of OncLive®, stated, “It is our
privilege and honor to rightfully recognize each of these honorees along
with former Vice President Joe Biden for the positive impact they have
made in the gastrointestinal cancer community. Each of these remarkable
individuals has worked hard to make a difference in improving the lives
of gastrointestinal cancer patients, families and survivors.”

The Ruesch Center for the Cure of Gastrointestinal Cancers is part of
the Georgetown Lombardi Comprehensive Cancer Center and focuses on
personalized patient care and fighting against gastrointestinal cancers.
The Ruesch Center provides the highest standard of care and
individualized cures through clinical trials and research, education and
advocacy, and regional and global alliances.

For more information, please visit https://www.onclive.com/luminary-awards
or follow OncLive® on Twitter
and The Ruesch Center for the Cure of Gastrointestinal Cancers on Twitter.

OncLive®

A digital platform of resources for practicing oncologists, OncLive®
offers oncology professionals information they can use to help provide
the best patient care. OncLive.com is the official website for the MJH
Associates Inc. Oncology Specialty Group, which publishes OncologyLive®,
Oncology Nursing News® and more. MJH Associates Inc. is a
full-service health care communications company offering education,
research and medical media, including curetoday.com and CURE®
magazine, the largest U.S. consumer publication focused entirely on
cancer. Combining science and humanity to make cancer understandable, CURE®
reaches patients, cancer centers and advocacy groups.

Contacts

OncLive® Media Contacts:
Alexandra Ventura
609-716-7777,
ext. 121
aventura@mjhassoc.com

John
Patricolo
609-325-4630
jpatricolo@mjhassoc.com

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.com for scheduling information.